Strategy
MSTR
MARA Holdings
MARA
Coinbase
COIN
NVIDIA
NVDA
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
CTOR Citius Oncology
- 1.081
- +0.041+3.94%
Trading Mar 4 14:04 ET
77.35MMarket Cap-3.35P/E (TTM)
1.140High1.020Low46.72KVolume1.020Open1.040Pre Close51.43KTurnover0.85%Turnover RatioLossP/E (Static)71.55MShares49.00052wk High1.87P/B5.95MFloat Cap0.85052wk Low--Dividend TTM5.50MShs Float49.000Historical High--Div YieldTTM11.54%Amplitude0.850Historical Low1.100Avg Price1Lot Size
Citius Oncology Key Stats
Quarterly+Annual
YOY
| (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (FY)Sep 30, 2022 | |
|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expense | 39.52%6.39M | 69.72%20.57M | 4.58M | 149.58%12.12M | 4.86M |
| Selling and administrative expenses | 49.36%5.13M | 98.56%15.65M | --3.43M | 451.59%7.88M | --1.43M |
| -General and administrative expense | 49.36%5.13M | 98.56%15.65M | --3.43M | 451.59%7.88M | --1.43M |
| Research and development costs | 10.10%1.26M | 16.14%4.93M | --1.15M | 23.71%4.24M | --3.43M |
| Operating profit | -39.52%-6.39M | -69.72%-20.57M | -4.58M | -149.58%-12.12M | -4.86M |
| Net non-operating interest income expense | |||||
| Other net income (expense) | |||||
| Income before tax | -39.52%-6.39M | -69.72%-20.57M | -4.58M | -149.58%-12.12M | -4.86M |
| Income tax | 83.50%264.24K | 0.00%576K | 144K | 0.00%576K | 576K |
| Net income | -40.86%-6.66M | -66.56%-21.15M | -4.73M | -133.72%-12.7M | -5.43M |
| Net income continuous Operations | -40.86%-6.66M | -66.56%-21.15M | ---4.73M | -133.72%-12.7M | ---5.43M |
| Minority interest income | |||||
| Net income attributable to the parent company | -40.86%-6.66M | -66.56%-21.15M | -4.73M | -133.72%-12.7M | -5.43M |
| Preferred stock dividends | |||||
| Other preferred stock dividends | |||||
| Net income attributable to common stockholders | -40.86%-6.66M | -66.56%-21.15M | -4.73M | -133.72%-12.7M | -5.43M |
| Basic earnings per share | -35.63%-0.09 | -73.93%-0.31 | -0.0664 | -133.72%-0.1782 | -0.0763 |
| Diluted earnings per share | -35.63%-0.09 | -73.93%-0.31 | -0.0664 | -133.72%-0.1782 | -0.0763 |
| Dividend per share | |||||
| Currency Unit | USD | USD | USD | USD | USD |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.